blood donors who attended at Transfusion Medicine Department at DMCH, 25,773 were relative donors and remaining 6117 were voluntary donors The age distribution of donor was 18 -60 years. Blood donors were selected after proper history taking and physical examination of donor which includes pulse, blood pressure, weight and Hb% .Prepared questionnaire in national language were used for selection of donor. Those who were illiterate assisted by donor registration stuff. Consent obtained in writing form from the donor after explaining the procedure, potential adverse reactions as well as the tests carried out on the donated blood .Some donors were rejected by self exclusion during conversation. Finally reviewed donor's health condition and performing physical examination / Hb estimation with scala matching method by principal author. After fulfilling the criteria of donor selection with all aseptic precaution 5 ml of blood was collected in prelabeled pilot tube. Centrifuged the
Introduction
Transmission of infectious diseases through donated blood is of concern in order to provide safe blood for transfusion which forms an integral part of medical and surgical therapy. Blood transfusion carries the risk of transfusion induced transmissible infections including HIV, hepatitis, syphilis, malaria and less frequently toxoplasmosis, brucellosis and some viral infections like EpsteinBarr virus, cytomegalovirus and herpes 1 . Hepatitis C virus (HCV) infection is an important global health problem and may cause acute and chronic infection in man and is one of the most common causes of chronic liver disease, cirrhosis of liver and hepatocellular carcinoma. HCV accounts for 40% of chronic liver disease 2 . It is estimated that about 3% of global population is infected with HCV although prevalence ranges from 0.1 to more than 12%, depending on country which equals to approximately 170 million chronic carriers worldwide 3 . The first reports of hepatitis following a blood transfusion occurred in 1943 4 .
Sero-Prevalence of Anti HCV Among Blood Donors Attended at
Transfusion Medicine Department of DMCH in 2013 10 . In Bangladesh, 0.024% were positive for anti-HCV 11 . In Kathmandu, Nepal, seroprevalence of HCV was observed to be 0.64% 12 . Low prevalence rate in our study due to proper donor selection, blood screening and public awareness about HCV infection.
Conclusion
Post transfusion hepatitis will be significantly reduced through proper donor selection and screening of donated blood. HCV sero positive donors should be informed about their disease, counseled and sent for confirmation to referral laboratory. After confirmation seropositive donor should referred to hepatologist for proper management. Save the patient as well as donor. blood and separated the serum from cell. Detection of Anti-HCV antibody was done by Latex agglutination immuno chromatographic test with the instruction of reagent manufacture. The tests were reconfirmed by using ELISA method.
Results
The data was collected from the registered of 
